Showing results (2251-2260 of 2,541) with videos related to
Sort By:
Pageof 255
Materials (Basel, Switzerland)|August 11, 2017
Electrical Properties and Interfacial Studies of HfTi1-O₂ High Permittivity Gate Insulators Deposited on Germanium SubstratesQifeng Lu, Yifei Mu, Joseph W Roberts, et al.Nature|January 15, 2025
Engineered enzymes for enantioselective nucleophilic aromatic substitutionsThomas M Lister, George W Roberts, Euan J Hossack, et al.British Journal of Haematology|May 7, 2015
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignanciesAndrew W Roberts, Ranjana H Advani, Brad S Kahl, et al.Neurology|May 27, 2006
Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson diseaseC P Zabetian, H Morino, H Ujike, et al.The Journal of Clinical Investigation|May 20, 2006
SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritisPeter K K Wong, Paul J Egan, Ben A Croker, et al.Proceedings of the National Academy of Sciences of the United States of America|January 26, 2011
A gradient of childhood self-control predicts health, wealth, and public safetyTerrie E Moffitt, Louise Arseneault, Daniel Belsky, et al.Archives of Neurology|March 12, 2008
Glucocerebrosidase gene mutations: a risk factor for Lewy body disordersIgnacio F Mata, Ali Samii, Seth H Schneer, et al.The ISME Journal|September 29, 2012
Photophysiology and albedo-changing potential of the ice algal community on the surface of the Greenland ice sheetMarian L Yallop, Alexandre M Anesio, Rupert G Perkins, et al.Blood|March 13, 2015
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosisRami S Komrokji, John F Seymour, Andrew W Roberts, et al.Blood Advances|July 24, 2026
Long-term outcomes with continuous venetoclax for relapsed chronic lymphocytic leukemiaSean McKeague, Thomas E Lew, Anna Lowe, et al.Pageof 255